Invention Grant
- Patent Title: Oral formulations and lipophilic salts of methylnaltrexone
- Patent Title (中): 口服制剂和甲基纳曲酮的亲脂性盐
-
Application No.: US13045108Application Date: 2011-03-10
-
Publication No.: US08524276B2Publication Date: 2013-09-03
- Inventor: Syed M. Shah , Christopher Richard Diorio , Eric C. Ehrnsperger , Xu Meng , Kadum A. Al Shareffi , Jonathan Marc Cohen
- Applicant: Syed M. Shah , Christopher Richard Diorio , Eric C. Ehrnsperger , Xu Meng , Kadum A. Al Shareffi , Jonathan Marc Cohen
- Applicant Address: US NJ Madison
- Assignee: Wyeth, LLC
- Current Assignee: Wyeth, LLC
- Current Assignee Address: US NJ Madison
- Agency: McCarter & English, LLP
- Agent Jonathan M. Sparks; Maneesh Gulati
- Main IPC: A61K9/20
- IPC: A61K9/20
Abstract:
The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration.
Public/Granted literature
- US20120070495A1 ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE Public/Granted day:2012-03-22
Information query
